How many insider declarations has Qiming U.S. Healthcare Fund II, L.P. filed?

Qiming U.S. Healthcare Fund II, L.P. has filed 5 public insider declarations with SEC (Form 4).

What is Qiming U.S. Healthcare Fund II, L.P.'s role?

Qiming U.S. Healthcare Fund II, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Qiming U.S. Healthcare Fund II, L.P. report trades for?

Qiming U.S. Healthcare Fund II, L.P. reports trades for 3 companies, including Elevation Oncology, Inc..

What is Qiming U.S. Healthcare Fund II, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 3.7M€ and disposals 0.

← Executives ★ Sign in to follow

QU

Qiming U.S. Healthcare Fund II, L.P.

Other

US·SEC (Form 4)

Elevation Oncology, Inc.Icosavax, Inc.Jasper Therapeutics, Inc.

0

Total declarations

0

Companies

€4m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the full record of transactions filed by Qiming U.S. Healthcare Fund II, L.P.. Director active across 3 companies, notably Elevation Oncology, Inc.. In total, 5 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €3.7m. Activity tracked since 29 June 2021. The latest transaction was filed on 27 January 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Declarations5 total

▲

Qiming U.S. Healthcare Fund II, L.P.

Executives27 Jan 2023Jasper Therapeutics, Inc.

$4M26SEC ↗

2,666,666 shares@ US$1.50100.0% of flowVoting Common StockSEC:0001209191-23-024058:0